Tumor Ablation Market size is expected to reach nearly US$ 1.04 Bn. by 2026 with the CAGR of 12.4% during the forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
Tumor Ablation Market Dynamics:Tumor ablation is a minimally invasive cancer procedure. That is generally used in the treatment of tumors of liver, kidney, bone, and lung. In the tumor ablation procedure, special probes are used to burn or freeze tumor without the surgery. Tumor ablation is a device operated to treat cancerous malignancy. Tumor ablation is the process of removing the cancerous cells from the body. High prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis), the Rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research would create commercial market opportunities. The hugely unused markets in the developing countries are creating a lot of opportunities for the tumor ablation market. Furthermore, unfavorable reimbursement scenario and cost containment measures adopted by a government are the major hindrance of the market growth. Tumor Ablation market is segmented by technology, mode of treatment, application, and region. Among technology, microwave ablation and radiofrequency (RF) ablation is expected to grow at the fastest rate owing various benefits offered by this technology. This technology would continue to dominate the market during the forecast period owing to increasing demand for minimally invasive cancer procedures. Radiofrequency ablation technology is the most commonly used therapy for liver cancer. It will grow at a significant rate due to approximately XX% and more success rate for eliminating small liver tumors. Among applications, liver cancer segment is predicted to grow at fastest rate due to the rise in the incidence of the bile duct and primary liver cancer.
Tumor Ablation Market Regional Analysis:Among regions, the North America region is expected to grow at the highest CAGR of XX% during the forecast period due to the remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology. The APAC region is expected to grow at the highest CAGR of XX% during the forecast period due to the increasing elderly population in the region. The high percentage of the elderly population in developing countries such as China and Japan are increasing the incidence of major types of cancer in the Asia Pacific region. Rising per capita income, rapid urbanization, and expansion of advanced healthcare facilities in developing economies are likely to offer profitable opportunities to vendors in tumor ablation market. The objective of the report is to present a comprehensive analysis of Global Tumor Ablation Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Tumor Ablation Market dynamics, structure by analyzing the market segments and project the Global Tumor Ablation Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Global Tumor Ablation Market make the report investor’s guide.
Tumor Ablation Market, Key Highlights:• Tumor Ablation Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Tumor Ablation Market • Tumor Ablation Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Tumor Ablation Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Tumor Ablation Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Tumor Ablation Market are also profiled.
Scope of the Tumor Ablation Market :
• Tumor Ablation Market, by Technology• Radiofrequency (RF) Ablation • Microwave Ablation • Cryoablation • Other Technologies
• Tumor Ablation Market, by Mode of Treatment• Percutaneous Ablation • Laparoscopic Ablation • Surgical Ablation
Market, by Application• Liver Cancer • Lung Cancer • Kidney Cancer • Bone Metastasis • Others
Market by region• North America • Europe • APAC • Latin America • MEA
Tumor Ablation Market Key Players• Medtronic plc • Angiodynamics, Inc. • Koninklijke Philips N.V • Spectranetics, Boston Scientific Corporation • Galil Medical, Inc. • EDAP TMS S.A. • Healthtronics, Inc. • Medtronic, Plc • Mermaid Medical, Inc. • Mesonix, Inc. • Neuwave Medical, Inc. • Sonacare Medical, LLC (U.S.) • Galil Medical Inc. • Misonix Inc. • HealthTronics • Mermaid Medical • Theraclion • Chongqing Haifu Medical Technology Co., Ltd. • HS Hospital Service S.P.A • EDAP TMS S.A.
Tumor Ablation Market1. INTRODUCTION 1.1 Report Description 1.1.1 Objectives of the Study 1.1.2 Market Scope 1.1.3 Years considered in the study 1.1.4 Currency 1.1.5 Stakeholders 1.2 Target Audience 1.3 Key Takeaways 2. RESEARCH METHODOLOGY 2.1 Research Methodology 2.2 Market Definition 2.3 Assumptions and Acronyms Used 2.4 Data Sources 2.4.1 Secondary 184.108.40.206 Paid 220.127.116.11 Unpaid 2.4.2 Primary 2.5 Analyst tools and models 3. EXECUTIVE SUMMARY 3.1 Tumor Ablation Market Overview 3.1.1 Tumor Ablation Market : By Technology 3.1.2 Tumor Ablation Market : By Application 3.1.3 Tumor Ablation Market : By Mode of Treatment 3.1.4 Tumor Ablation Market : By Region 4. TUMOR ABLATION MARKET OUTLOOK 4.1 Tumor Ablation Market : Market Definition, Segmentation and Scope of Study 4.2 Tumor Ablation Market : Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Tumor Ablation Market : Competitive Analysis 4.3.1 Key Strategic Initiatives 4.3.2 Regional Presence 4.3.3 Product Overview 4.4 Tumor Ablation Market : Porter’s Analysis 4.5 Tumor Ablation Market : PESTEL Analysis 4.6 Tumor Ablation Market : Product Benchmark Analysis 4.7 Tumor Ablation Market : Company Market Share Analysis 4.8 Tumor Ablation Market : Key Findings 4.8.1 Tumor Ablation Market : Top Wining Strategies 4.8.2 Tumor Ablation Market : Top Investment Pockets 4.8.3 Tumor Ablation Market : Top Impacting Factors 4.8.4Key Trends in Global Tumor Ablation Market 5. TUMOR ABLATION MARKET, BY TECHNOLOGY 5.1 Tumor Ablation Market : Technology segment Market Share analysis 5.2 Tumor Ablation Market : Technology segment Market Size and Forecast 2019-2026 5.3 Tumor Ablation Market by Radiofrequency (RF) Ablation 5.4 Tumor Ablation Market by Microwave Ablation 5.5 Tumor Ablation Market by Cryoablation 5.6 Tumor Ablation Market by Other Technologies 5.7 Tumor Ablation Market Benchmarking By Technology 5.8 Tumor Ablation Market by Technology : Key Trends 5.9 Tumor Ablation Market by Technology : Key Developments 6. TUMOR ABLATION MARKET , BY APPLICATION 6.1 Tumor Ablation Market : application segment Market Share Analysis 6.2 Tumor Ablation Market : application segment Market Size and Forecast 2019-2026 6.3 Tumor Ablation Market by Liver Cancer 6.4 Tumor Ablation Market by Lung Cancer 6.5 Tumor Ablation Market by Kidney Cancer 6.6 Tumor Ablation Market by Bone Metastasis 6.7 Tumor Ablation Market by Others 6.8 Tumor Ablation Market Benchmarking By Application 6.9 Tumor Ablation Market by Application: Key Trends 6.10 Tumor Ablation Market by Application: Key Developments 7. TUMOR ABLATION MARKET, BY MODE OF TREATMENT 7.1 Tumor Ablation Market : Mode of Treatment segment Market Share analysis 7.2 Tumor Ablation Market : Mode of Treatment segment Market Size and Forecast 2019-2026 7.3 Tumor Ablation Market by Percutaneous Ablation 7.4 Tumor Ablation Market by Laparoscopic Ablation 7.5 Tumor Ablation Market by Surgical Ablation 7.6 Tumor Ablation Market Benchmarking By Mode of Treatment 7.7 Tumor Ablation Market by Mode of Treatment: Key Trends 7.8 Tumor Ablation Market by Mode of Treatment: Key Developments 8. TUMOR ABLATION MARKET , BY GEOGRAPHY 8.1 Tumor Ablation Market : Geography segment Market Share Analysis 8.2 Tumor Ablation Market : Geography segment Market Size and Forecast 2019-2026 8.3 North America 8.3.1 Overview 8.3.2 Tumor Ablation Market Size and Forecast, by Technology 2019-2026 8.3.3 Tumor Ablation Market Share Analysis , by Technology 2019-2026 8.3.4 Tumor Ablation Market Size and Forecast, by Application 2019-2026 8.3.5 Tumor Ablation Market Share Analysis , by Application 2019-2026 8.3.6 Tumor Ablation Market Size and Forecast, by Mode of Treatment 2019-2026 8.3.7 Tumor Ablation Market Share Analysis , by Mode of Treatment 2019-2026 8.4 Europe 8.4.1 Overview 8.4.2 Tumor Ablation Market Size and Forecast, by Technology 2019-2026 8.4.3 Tumor Ablation Market Share Analysis , by Technology 2019-2026 8.4.4 Tumor Ablation Market Size and Forecast, by Application 2019-2026 8.4.5 Tumor Ablation Market Share Analysis , by Application 2019-2026 8.4.6 Tumor Ablation Market Size and Forecast, by Mode of Treatment 2019-2026 8.4.7 Tumor Ablation Market Share Analysis , by Mode of Treatment 2019-2026 8.5 Asia Pacific 8.5.1 Overview 8.5.2 Tumor Ablation Market Size and Forecast, by Technology 2019-2026 8.5.3 Tumor Ablation Market Share Analysis , by Technology 2019-2026 8.5.4 Tumor Ablation Market Size and Forecast, by Application 2019-2026 8.5.5 Tumor Ablation Market Share Analysis , by Application 2019-2026 8.5.6 Tumor Ablation Market Size and Forecast, by Mode of Treatment 2019-2026 8.5.7 Tumor Ablation Market Share Analysis , by Mode of Treatment 2019-2026 8.6 Latin America, Middle East and Africa 8.6.1 Overview 8.6.2 Tumor Ablation Market Size and Forecast, by Technology 2019-2026 8.6.3 Tumor Ablation Market Share Analysis , by Technology 2019-2026 8.6.4 Tumor Ablation Market Size and Forecast, by Application 2019-2026 8.6.5 Tumor Ablation Market Share Analysis , by Application 2019-2026 8.6.6 Tumor Ablation Market Size and Forecast, by Mode of Treatment 2019-2026 8.6.7 Tumor Ablation Market Share Analysis , by Mode of Treatment 2019-2026 8.7 Tumor Ablation Market Benchmarking By Geography 8.8 Tumor Ablation Market by Geography : Key Trends 8.9 Tumor Ablation Market by Geography : Key Developments 9. COMPETITIVE LANDSCAPE 9.1 Tumor Ablation Market Share/ Positioning Analysis 9.2 Tumor Ablation Market: Key Innovators 9.3 Tumor Ablation Market : Company Profiles 9.3.1 Medtronic plc 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.2 Angiodynamics, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.3 Koninklijke Philips N.V 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.4 Spectranetics, Boston Scientific Corporation 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.5 Galil Medical, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.6 EDAP TMS S.A. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.7 Healthtronics, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.8 Medtronic, Plc 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.9 Mermaid Medical, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.10 Mesonix, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.11 Neuwave Medical, Inc. 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.12 Sonacare Medical, LLC (U.S.) 18.104.22.168 Overview 22.214.171.124 Product/Service Portfolio 126.96.36.199 Key Financials 188.8.131.52 Strategic Initiatives 184.108.40.206 SWOT Analysis 220.127.116.11 Competitive Assessment 9.3.13 Galil Medical Inc. 9.3.14 Misonix Inc. 9.3.15 HealthTronics 9.3.16 Mermaid Medical 9.3.17 Theraclion 9.3.18 Chongqing Haifu Medical Technology Co., Ltd. 9.3.19 HS Hospital Service S.P.A 9.3.20 EDAP TMS S.A. 10. CONSOLIDATION 10.1 Tumor Ablation Market: Mergers and Acquisitions 10.1.1 Overview 10.1.2 Tumor Ablation Market : Key Drivers – By Region 10.1.3 Tumor Ablation Market : M&A Breakdown 10.1.3.1 Technology Based 10.1.3.2 Application Based 10.1.3.3 Mode of treatment Based 10.1.3.4 Niche Based 10.1.3.5 Region Based 10.1.3.6 Asset & Non-Asset Based 10.1.3.7 Venture Capitalist Based 10.2 Fragmentation of Tumor Ablation Market 10.3 Tumor Ablation Market : Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 10.4 Tumor Ablation Market - New/Emerging Models of Partnerships : Key Examples 10.5 Tumor Ablation Market : New/Emerging Business Models : Key Examples 10.6 Tumor Ablation Market - Changing Investment Paradigm : Focused areas by Key Players 10.7 Tumor Ablation Market - Patent Analysis 11. Tumor Ablation Market: LIST OF TABLES 12. Tumor Ablation Market: LIST OF FIGURES